Our results show an evident increase in prostate weight (Figure 2A) and TGF-β expression (Figure 2B,C) in BPH-treated rats which um-PEA/Baic (10 mg/kg) treatment significantly reduced. The gene discussed is TGFB1; the disease is benign prostatic hyperplasia.